Vertex Pharmaceuticals Inc
DUS:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
DUS:VX1
|
US |
|
Promotora de Informaciones SA
MAD:PRS
|
ES |
|
B
|
Bumi Resources Minerals Tbk PT
XMUN:BUR
|
ID |
|
A
|
Avis Budget Group Inc
XMUN:CUCA
|
US |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
B
|
Bank of China Ltd
OTC:BACHF
|
CN |
|
Corporate Travel Management Ltd
ASX:CTD
|
AU |
|
V
|
Vinci SA
DUS:SQU
|
FR |
|
A
|
Autodesk Inc
F:AUD
|
US |
|
Compania de Minas Buenaventura SAA
F:MBU
|
PE |
|
Windar Photonics PLC
F:7WP
|
DK |
|
I
|
Infineon Technologies AG
XMUN:IFX
|
DE |
|
Swisscom AG
SIX:SCMN
|
CH |
|
L
|
LSI Industries Inc
F:LS2
|
US |
|
C
|
Coats Group PLC
F:4TC
|
UK |
|
Infineon Technologies AG
F:IFXA
|
DE |
|
Astellas Pharma Inc
F:YPHA
|
JP |
|
D
|
Daiichi Life Group Inc
XMUN:QHH
|
JP |
|
O
|
Old National Bancorp
F:ON1
|
US |
Intrinsic Value
Is VX1 undervalued or overvalued?
See the intrinsic value estimate for 
Vertex Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Vertex Pharmaceuticals Does
Vertex Pharmaceuticals is a biotech company that discovers and sells prescription medicines for serious diseases. Its best-known business is cystic fibrosis treatment, where it develops drugs that help correct the underlying protein defect that causes the disease. It also works on medicines for pain, sickle cell disease, beta thalassemia, and other hard-to-treat conditions.
- Headquarters
- United States of America US
- Employees
- 6 400
- IPO date
- Jul 24, 1991
Vertex Pharmaceuticals has a narrow economic moat
Patents covering Vertex’s cystic fibrosis medicines prevent rivals from selling copies, protecting its profits. Competitors must develop and win approval for their own treatments rather than simply reproduce medicines such as Trikafta and Alyftrek.
Read the full moat analysis
Revenue & Expenses Breakdown
Vertex Pharmaceuticals Inc
Earnings Waterfall
Vertex Pharmaceuticals Inc
The intrinsic value for Vertex Pharmaceuticals Inc (VX1) under the Base Case is hidden EUR.
Compared with the current market price of 476.3 EUR, the stock appears hidden.
